![Faculty Opinions recommendation of Comparison of the novel subtype-selective GABAA receptor-positive allosteric modulator NS11394 [3'-[5-(1-hydroxy-1-methyl-ethyl)-benzoimidazol-1-yl]-biphenyl-2-carbonitrile] with diazepam, zolpidem, bretazenil, and gaboxadol in rat models of inflammatory and neuropathic pain.](/static/images/no-image.png)
Journal article
Faculty Opinions recommendation of Comparison of the novel subtype-selective GABAA receptor-positive allosteric modulator NS11394 [3'-[5-(1-hydroxy-1-methyl-ethyl)-benzoimidazol-1-yl]-biphenyl-2-carbonitrile] with diazepam, zolpidem, bretazenil, and gaboxadol in rat models of inflammatory and neuropathic pain.
- Zeilhofer, Hanns Ulrich ORCID Institute for Pharmacology and Toxicology, University of Zurich, Switzerland
- Broll, Ilja Institute of Pharmacology & Toxicology, University of Zurich, Switzerland
Published in:
- Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature. - Faculty Opinions Ltd. - 2009
- Language
-
- English
- Open access status
- closed
- Identifiers
- Persistent URL
- https://sonar.ch/global/documents/193568
Statistics
Document views: 8
File downloads: